Search PubMed⌕ Search

Biomedical subjects

R Lindskov

Publications and source records attributed to R Lindskov.

25 records · Page 2Linked to original sources

Oral disodium cromoglycate treatment of atopic dermatitis.

Fourteen adults and 10 children with active atopic dermatitis entered this double blind cross-over study of oral disodium cromoglycate (DSCG) (adults 200 mg qid, children 100 mg qid) compared with placebo. Oral DSCG and placebo were given for 6 weeks in random order. According to the investigators' assessments of eczema, significant differences between active and placebo were found after 6 weeks' treatment, DSCG being favoured (P less than 0.05). No differences were detected in the investigators' assessment of lichenization and overall disease. No significant differences between the two treatments were demonstrated in the patients' assessments. Results from food allergic patients were similar to those from non-food allergic patients. Two patients reported possible side effects of arthralgia and urticaria respectively. There were no treatment effects on serum IgE values or any other laboratory data.

Administration, Oral↗

Discoid lupus erythematosus and carrier status of X-linked chronic granulomatous disease.

Discoid lupus erythematosus (DLE)-like lesions and recurrent aphthous-like stomatitis have often been described in carriers of X-linked chronic granulomatous disease (CGD). The capacity of the polymorphonuclear leucocytes to reduce nitroblue tetrazolium (NBT) after stimulation with phorbol myristate acetate (NBT test), a function of normal oxidative metabolism, was determined in 34 patients with DLE of whom 17 also suffered from recurrent stomatitis. The NBT test turned out to be normal in all 34 patients, indicating that none of them were carriers of X-linked CGD. In spite of the negative results of this study it is recommended that all female patients suffering from DLE in combination with recurrent aphthous-like stomatitis are screened by means of the NBT test, because this examination is simple and inexpensive, and because of the importance of identifying carriers of CGD with a view to genetic guidance.

Adolescent↗

Pityriasis amiantacea and psoriasis. A follow-up study.

59 patients with pityriasis amiantacea (PA) were followed up after 8 years on average. 15% had suffered from psoriasis and 19% were aware of psoriasis in their relatives. The incidence of psoriasis was significantly higher (p less than 0.01) than in the Scandinavian population, and the predisposition to psoriasis was significantly higher than in the population (p less than 0.001), but significantly lower (p less than 0.01) than in psoriatic patients. PA seems to be a manifestation of psoriasis in many cases.

Adolescent↗

Skin carcinomas and treatment with photochemotherapy (PUVA).

A 3 1/2-year follow-up study of 198 patients treated with photochemotherapy (PUVA) revealed a total of 18 carcinomas developed in 11 patients. There were 12 basal cell carcinomas and 6 squamous cell carcinomas, localized mainly on non-sun-exposed areas. Furthermore 9 actinic keratoses were diagnosed in 8 patients. All patients with carcinomas had been exposed to at least one of the following possible risk factors; ionizing radiation, methotrexate (MTX), arsenic, topical nitrogen mustard, or had a history of skin carcinoma previous to PUVA therapy. No significant differences in accumulated UVA dose existed between patients with carcinoma or keratosis and patients without tumours. A subgroup of 38 psoriatics previously treated with MTX was compared with a control group of 101 psoriatics treated with MTX--but never with PUVA. The control group was matched for sex, age and presence of the risk factors: ionizing radiation, arsenic and history of carcinoma. The carcinoma incidence in the PUVA-MTX group was 9% and in the control group 11%. The difference was not significant (p = 0.9).

Adult↗